Swedish toddlers set to receive swine flu vaccine
The swine flu vaccine will soon be available to all children younger than three-years-old, according to Swedish health authorities.
Currently, children under the age of three are only vaccinated if they are deemed to belong to a designated risk group.
In general, parents have been advised to abstain from having small children vaccinated because of a lack of information regarding the vaccine's side effects on children under three.
However, the Medical Products Agency (Läkemedelsverket), which oversees Sweden’s vaccination programme, is expected to review the current regulations next week, the Svenska Dagbladet (SvD) newspaper reports.
The review follows the receipt of preliminary results from the first vaccine study which show that there are no more side effects for young children than for other age groups.
Following the review, the vaccine will likely be made available to all children between six-months- and three-years-old.
“The recommendations for children under three will likely come within a few weeks,” Jan Liliemark, a professor with the Medical Products Agency, told Sveriges Television (SVT).
The primary motivation for changing the recommendations is that children under two-years-old are especially vulnerable, both when it comes to infection and risk of death.
Comments
See Also
Currently, children under the age of three are only vaccinated if they are deemed to belong to a designated risk group.
In general, parents have been advised to abstain from having small children vaccinated because of a lack of information regarding the vaccine's side effects on children under three.
However, the Medical Products Agency (Läkemedelsverket), which oversees Sweden’s vaccination programme, is expected to review the current regulations next week, the Svenska Dagbladet (SvD) newspaper reports.
The review follows the receipt of preliminary results from the first vaccine study which show that there are no more side effects for young children than for other age groups.
Following the review, the vaccine will likely be made available to all children between six-months- and three-years-old.
“The recommendations for children under three will likely come within a few weeks,” Jan Liliemark, a professor with the Medical Products Agency, told Sveriges Television (SVT).
The primary motivation for changing the recommendations is that children under two-years-old are especially vulnerable, both when it comes to infection and risk of death.
Join the conversation in our comments section below. Share your own views and experience and if you have a question or suggestion for our journalists then email us at [email protected].
Please keep comments civil, constructive and on topic – and make sure to read our terms of use before getting involved.
Please log in here to leave a comment.